Salzburg Global Seminar Home Salzburg Global Seminar Mission

Session Links
 
Stay in Touch with Facebook! Watch our Videos! Follow us on Twitter! Join our LinkedIn Network! Subscribe to our Newsletter!
 
Alternate Systems and Structures for Higher Education: Public Needs and Institutional Response for the 21st Century 
Biotechnology: Policy Issues and Regulatory Frameworks
12 Jul - 19 Jul, 2000
 Transnational Perspectives on Intellectual Property and Communication Law

Faculty:
Michael Morgan (Chair) - Chief Executive, The Wellcome Trust Genome Campus at Hinxton, Cambridge; Head of Directly Managed Major Initiatives, The Wellcome Trust, London
Alan Colman - Research Director, PPL Therapeutics, Scotland
Michael Kirby - Justice, High Court of Australia; Member, International Bioethics Committee of UNESCO; Member, Ethics Committee, Human Genome Organisation, London
Kim Nasmyth - Director, Institute for Molecular Pathology, Vienna
Pauline Newman - Federal Judge, U.S. Court of Appeals, Washington, D.C.
James Watson  
Yang Huanming - Director, Human Genome Center, Institute of Genetics, Chinese Academy of Sciences, Beijing

Abstract:
Few scientific developments have been more vigorously debated than current advances in biotechnology. While gene modification promises dramatic opportunities for enhancing healthcare and agricultural production and offers new possibilities for the chemical and manufacturing industries, these same developments have provoked intense public concern. Advances in biotechnology have raised fears about the power of scientists to “play God” and have prompted calls for controls on the scientific community.

This session will convene scientists, legislators, policy-makers, public opinion leaders, and representatives from the private sector for an in-depth examination of the appropriate regulatory framework to enable scientific knowledge to be translated into new products for human health and wealth while protecting and fostering the public good. Discussions will address how different cultures respond to advances in biotechnology and what international implications these differing responses might have; how the public can gain access to adequate and impartial information about biotechnological developments; and to what degree the private sector, the scientific community, and the public sector can work together to assure the responsible advancement of biotechnology.


back

ABOUT US
Mission
Board of Directors
Staff Directory
A Brief History
Contact Information
SGS In The Community
President's Reports
Audit Reports
Careers & Internships
Commitment to Sustainablilty

NEWS

PROGRAMS
Registration Information
Calendar
Upcoming Programs
American Studies Programs
The Global Prevention of Genocide
Global Citizenship Program
Optimizing Institutional Philanthropy
Reform and Transformation in the
   Middle East & North Africa

Salzburg Academy on Media
   and Global Change

ISSUES
American Studies
Culture & The Arts
Economics & Finance
Education
Genocide Studies & Prevention
Geopolitics
Global Citizenship
Global Media Literacy
Health & Healthcare Innovation
Philanthropy Studies
Reform & Transformation
   in the Middle East

FELLOWS
The Salzburg Global
   Fellowship

Fellowship Events

MEDIA
Videos
Podcasts
Newsletter
Press
In the News
Publications

ARCHIVES
Past Sessions
Past Initiatives

SUPPORT OUR WORK

 

SALZBURG GLOBAL SEMINAR
LEOPOLDSKRONSTRASSE 56
SALZBURG, AUSTRIA
TEL: +43 662 839 830
FAX: +43 662 839 8309
info@salzburgglobal.org

© 2019 Salzburg Global Seminar